Ischaemic neurological deficit after sclerotherapy.
Trenkwalder
P
P
Lydtin
H
H
D006801:Humans; D002546:Ischemic Attack, Transient / Q000139:chemically induced*; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000009:adverse effects*; D012597:Sclerosing Solutions / Q000009:adverse effects*; D015911:Sclerotherapy / Q000009:adverse effects*; D014648:Varicose Veins / Q000628:therapy
D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols